Cannabinoids as therapeutics / edited by R. Mechoulam.
"In recent years, cannabis research has concentrated on the potential of cannabinoids as therapeutic substances, particularly in serious chronic illnesses such as multiple sclerosis. Most volumes published on cannabinoids so far concentrate on the biological activity, biochemistry and pharmacol...
Saved in:
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Format: | Ebook |
| Language: | English |
| Published: |
Basel ; Boston :
Birkhäuser,
c2005.
|
| Series: | Milestones in drug therapy.
|
| Subjects: | |
| Online Access: | Springer eBooks |
| Summary: | "In recent years, cannabis research has concentrated on the potential of cannabinoids as therapeutic substances, particularly in serious chronic illnesses such as multiple sclerosis. Most volumes published on cannabinoids so far concentrate on the biological activity, biochemistry and pharmacology, whereas this volume concentrates on the diseases, the physiological effects and therapeutic use of cannabinoids. The volume editor Prof. Mechoulam was the first who isolated the prime active constituent (THC, Tetrahydrocannabiol) of marijuana. He published extensively on the pharmacological activities of cannabinoids. The volume is of interest to researchers and clinicians from pharmacology, neuroscience, and medicinal research."--Publisher's website. |
|---|---|
| Item Description: | Description based on print version record. |
| Physical Description: | 1 electronic document. |
| Format: | Mode of access: World Wide Web. |
| Bibliography: | Includes bibliographical references and index. |
| ISBN: | 1280263806 376437358X 9781280263804 9783764373580 |